TitleProduct

Atezolizumab

  • Price:

    Negotiable

  • minimum:

  • Total supply:

  • Delivery term:

    The date of payment from buyers deliver within days

  • seat:

    Shanghai

  • Validity to:

    Long-term effective

  • Last update:

    2018-12-22 23:11

  • Browse the number:

    378

Send an inquiries
+
Shanghai TheraMabs Bio-Technology Co.,Ltd
Contactaixin:

saimai2018(Mr.)  

Email:

sales@theramabs.com

telephone:

+86-21-58582603

phone:

13611999090

Arrea:

Shanghai

Address:

Room 156, 133# Dongzheng Road, Pudong Disrict, Shanghai, China

Website:

http://www.therapeuticmab.com/ http://saimai2018.chinamerchants-logistics.com/

+

This product is the biosimilar of Atezolizumab (1380723-44-3), which is an Fc-engineered, humanized, monoclonal antibody that binds to PD-L1 and blocks interactions with the PD-1 and B7.1 receptors. the biosimilar is a non-glycosylated IgG1 kappa immunoglobulin that has a calculated molecular mass of 145 kDa, which was produced by CHO expression system.


Features and Advantages:

Name

Biosimilar of Atezolizumab

CAS NO.

1380723-44-3

Type

Whole antibody

Source

Humanized

Target

PD-L1

Clone

Monoclone

Molecular Weight

145 kDa

Formula

C6446H9902N1706O1998S42

Antibody Form

Purified immunoglobulin

Physical Form

Solution

Place of Origin

China (Mainland)

Storage

Sealed and stored at -70±15℃, away from light


Specifications:

My company's product is supplied at a concentration of 60 mg/mL, Antibody concentration, buffer system is consistent with the original drug (TECENTRIQ), In addition, customized services can also be provided according to customer needs.

Annual supply quantity is about 70~130kg, the minimum order is 1 gram, for more information please contact us.


Applications:

Atezolizumab, sold under the trade name TECENTRIQ, is a medication used to treat bladder cancer. The FDA also approved the Tecentriq auxiliary diagnostic reagent Ventana PD-L1 (SP142) analytical kit for the determination of the expression level of PD-L1 in tumor infiltrated immune cells. 

Our products are manufactured and filled in accordance with GMP production specifications, which is only used for preclinical trials and is strictly prohibited to be used for clinical and commercial usage before approve by FDA.


http://www.therapeuticmab.com/